These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7700027)

  • 1. Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro.
    Cheung AK; Parker CJ; Hohnholt M
    Kidney Int; 1994 Dec; 46(6):1680-7. PubMed ID: 7700027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2 integrins are required for neutrophil degranulation induced by hemodialysis membranes.
    Cheung AK; Parker CJ; Hohnholt M
    Kidney Int; 1993 Mar; 43(3):649-60. PubMed ID: 8455364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis.
    Himmelfarb J; McMonagle E; Holbrook D; Toth C
    J Lab Clin Med; 1995 Oct; 126(4):392-400. PubMed ID: 7561449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of complement activation with EDTA in vivo during sham hemodialysis.
    Kandus A; Benedik M; Bren AF; Drinovec J; Fliser D; Knap B; Kladnik S; Ivanovich P
    Int J Artif Organs; 1991 Aug; 14(8):515-7. PubMed ID: 1937941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence of neutrophils to hemodialysis membranes: role of complement receptors.
    Cheung AK; Hohnholt M; Gilson J
    Kidney Int; 1991 Dec; 40(6):1123-33. PubMed ID: 1762313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of a new high-flux cellulose acetate membrane.
    Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
    Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leukotrienes.
    Böhler J; Donauer J; Birmelin M; Schollmeyer PJ; Hörl WH
    Nephrol Dial Transplant; 1993; 8(12):1359-65. PubMed ID: 8159305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of dialysis membranes: effects of chronic complement activation.
    Hakim RM; Fearon DT; Lazarus JM
    Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
    Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
    Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan.
    Cheung AK; Parker CJ; Wilcox LA; Janatova J
    Kidney Int; 1990 Apr; 37(4):1055-9. PubMed ID: 2342244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis.
    Cheung AK; Faezi-Jenkin B; Leypoldt JK
    J Am Soc Nephrol; 1994 Jul; 5(1):110-5. PubMed ID: 7948777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of neutrophil activation by vitamin E modified dialyzer membranes.
    Omata M; Higuchi C; Demura R; Sanaka T; Nihei H
    Nephron; 2000 Jul; 85(3):221-31. PubMed ID: 10867537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellulose acetate hemodialysis membranes are better tolerated than Cuprophan. A difference in complement and neutrophil activation.
    Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
    Contrib Nephrol; 1984; 37():78-82. PubMed ID: 6713881
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.